UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 30, 2013

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

APPLE INC.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

938,649,000 shares of common stock issued and outstanding as of April 12,

2013

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

Six Months Ended

March 30,

2013

March 31,

2012

March 30,

2013

March 31,

2012

Net sales

43,603

39,186

98,115

85,519

Cost of sales

27,254

20,622

60,706

46,252

Gross margin

16,349

18,564

37,409

39,267

Operating expenses:

Research and development

1,119

841

2,129

1,599

Selling, general and administrative

2,672

2,339

5,512

4,944

Total operating expenses

3,791

3,180

7,641

6,543

Operating income

12,558

15,384

29,768

32,724

Other income/(expense), net

347

148

809

285

Income before provision for income taxes

12,905

15,532

30,577

33,009

Provision for income taxes

3,358

3,910

7,952

8,323

Net income

9,547

11,622

22,625

24,686

Earnings per share:

Basic

10.16

12.45

24.09

26.48

Diluted

10.09

12.30

23.90

26.17

Shares used in computing earnings per share:

Basic

939,629

933,582

939,273

932,265

Diluted

946,035

944,893

946,626

943,185

Cash dividends declared per common share

2.65

5.30

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

Six Months Ended

March 30,

2013

March 31,

2012

March 30,

2013

March 31,

2012

Net income

9,547

11,622

22,625

24,686

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax

(51

(77

Change in unrecognized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax

457

(21

603

66

Adjustment for net (gains)/losses realized and included in net income, net of tax

42

(97

154

(251

Total change in unrecognized gains/losses on derivative instruments, net of tax

499

(118

757

(185

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax

(52

276

(118

303

Adjustment for net (gains)/losses realized and included in net income, net of tax

(44

(27

(97

(40

Total change in unrealized gains/losses on marketable securities, net of tax

(96

249

(215

263

Total other comprehensive income/(loss)

352

140

465

81

Total comprehensive income

9,899

11,762

23,090

24,767

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands)

March 30,

2013

September 29,

2012

ASSETS:

Current assets:

Cash and cash equivalents

12,053

10,746

Short-term marketable securities

27,084

18,383

Accounts receivable, less allowances of $99 and $98, respectively

7,084

10,930

Inventories

1,245

791

Deferred tax assets

3,242

2,583

Vendor non-trade receivables

6,252

7,762

Other current assets

6,377

6,458

Total current assets

63,337

57,653

Long-term marketable securities

105,550

92,122

Property, plant and equipment, net

15,026

15,452

Goodwill

1,400

1,135

Acquired intangible assets, net

4,136

4,224

Other assets

5,294

5,478

Total assets

194,743

176,064

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

14,912

21,175

Accrued expenses

13,331

11,414

Deferred revenue

7,265

5,953

Total current liabilities

35,508

38,542

Deferred revenue non-current

2,877

2,648

Other non-current liabilities

20,868

16,664

Total liabilities

59,253

57,854

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000 shares authorized; 940,094 and 939,208 shares issued and outstanding,

respectively

17,954

16,422

Retained earnings

116,572

101,289

Accumulated other comprehensive income

964

499

Total shareholders equity

135,490

118,210

Total liabilities and shareholders equity

194,743

176,064

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Six Months Ended

March 30,

2013

March 31,

2012

Cash and cash equivalents, beginning of the period

10,746

9,815

Operating activities:

Net income

22,625

24,686

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

3,280

1,461

Share-based compensation expense

1,120

844

Deferred income tax expense

1,957

2,915

Changes in operating assets and liabilities:

Accounts receivable, net

3,846

(1,663

Inventories

(454

(326

Vendor non-trade receivables

1,510

(379

Other current and non-current assets

1,269

(1,510

Accounts payable

(4,422

2,809

Deferred revenue

1,541

1,916

Other current and non-current liabilities

3,658

778

Cash generated by operating activities

35,930

31,531

Investing activities:

Purchases of marketable securities

(81,163

(85,022

Proceeds from maturities of marketable securities

9,243

7,702

Proceeds from sales of marketable securities

49,188

49,052

Payments made in connection with business acquisitions, net

(299

(350

Payments for acquisition of property, plant and equipment

(4,325

(2,778

Payments for acquisition of intangible assets

(429

(160

Other

(93

(48

Cash used in investing activities

(27,878

(31,604

Financing activities:

Proceeds from issuance of common stock

275

377

Excess tax benefits from equity awards

502

636

Dividends and dividend equivalent rights paid

(4,984

Repurchase of common stock

(1,950

Taxes paid related to net share settlement of equity awards

(588

(634

Cash (used in)/generated by financing activities

(6,745

379

Increase in cash and cash equivalents

1,307

306

Cash and cash equivalents, end of the period

12,053

10,121

Supplemental cash flow disclosure:

Cash paid for income taxes, net

4,258

4,835

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses, and

education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions

have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the

amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and notes

thereto have been reclassified to conform to the current period s presentation.

These condensed consolidated financial

statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 29, 2012, included in its Annual Report on Form 10-K (the

2012 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2013 will include 52 weeks, whereas fiscal year 2012 included 53 weeks. An additional

week was included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to particular years, quarters or months refer to the Company s fiscal years

ended in September and the associated quarters or months of those fiscal years.

During the first quarter of 2013, the Company

adopted amended accounting standards that changed the presentation of comprehensive income. These standards increased the prominence of other comprehensive income ( OCI ) by eliminating the option to present components of OCI as part of

the statement of changes in shareholders equity and required the components of OCI to be presented either in a single continuous statement of comprehensive income or in two consecutive statements. The amended accounting standards only impacted

the financial statement presentation of OCI and did not change the components that are recognized in net income or OCI; accordingly, the adoption had no impact on the Company s financial position or results of operations.

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of

common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the

number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s

employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury

stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the

three- and six-month periods ended March 30, 2013 and March 31, 2012 (in thousands, except net income in millions and per share amounts):

Three Months Ended

Six Months Ended

March 30,

2013

March 31,

2012

March 30,

2013

March 31,

2012

Numerator:

Net income

9,547

11,622

22,625

24,686

Denominator:

Weighted-average shares outstanding

939,629

933,582

939,273

932,265

Effect of dilutive securities

6,406

11,311

7,353

10,920

Weighted-average diluted shares

946,035

944,893

946,626

943,185

Basic earnings per share

10.16

12.45

24.09

26.48

Diluted earnings per share

10.09

12.30

23.90

26.17

Potentially dilutive securities representing 4.3 million and 4.0 million shares of common stock

for the three- and six-month periods ended March 30, 2013, were excluded from the computation of diluted earnings per share because their effect would have been antidilutive. The number of potentially dilutive securities excluded from the

computation of diluted earnings per share because their effect would have been antidilutive was not significant for the three- and six-month periods ended March 31, 2012.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category

recorded as cash and cash equivalents or short- or long-term marketable securities as of March 30, 2013 and September 29, 2012 (in millions):

March 30, 2013

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

5,865

5,865

5,865

Level 1 (a):

Money market funds

2,027

2,027

2,027

Mutual funds

3,943

27

(45

3,925

3,925

Subtotal

5,970

27

(45

5,952

2,027

3,925

Level 2 (b):

U.S. Treasury securities

25,612

28

25,640

1,369

6,718

17,553

U.S. agency securities

21,174

34

(7

21,201

576

3,803

16,822

Non-U.S. government securities

5,036

115

(25

5,126

615

4,511

Certificates of deposit and time deposits

2,562

2,562

1,456

435

671

Commercial paper

2,108

2,108

739

1,369

Corporate securities

54,654

499

(39

55,114

21

9,403

45,690

Municipal securities

6,341

67

(3

6,405

816

5,589

Mortgage- and asset-backed securities

14,681

53

(20

14,714

14,714

Subtotal

132,168

796

(94

132,870

4,161

23,159

105,550

Total

144,003

823

(139

144,687

12,053

27,084

105,550

September 29, 2012

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

3,109

3,109

3,109

Level 1 (a):

Money market funds

1,460

1,460

1,460

Mutual funds

2,385

79

(2

2,462

2,462

Subtotal

3,845

79

(2

3,922

1,460

2,462

Level 2 (b):

U.S. Treasury securities

20,088

21

(1

20,108

2,608

3,525

13,975

U.S. agency securities

19,540

58

(1

19,597

1,460

1,884

16,253

Non-U.S. government securities

5,483

183

(2

5,664

84

1,034

4,546

Certificates of deposit and time deposits

2,189

2,191

1,106

202

883

Commercial paper

2,112

2,112

909

1,203

Corporate securities

46,261

568

(8

46,821

10

7,455

39,356

Municipal securities

5,645

74

5,719

618

5,101

Mortgage- and asset-backed securities

11,948

66

(6

12,008

12,008

Subtotal

113,266

972

(18

114,220

6,177

15,921

92,122

Total

120,220

1,051

(20

121,251

10,746

18,383

92,122

(a)

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

(b)

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and

liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

The net unrealized gains as of March 30, 2013 and September 29, 2012 are related primarily to

long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net

realized gains or losses recognized by the Company related to such sales were not significant during the three- and six-month periods ended March 30, 2013 and March 31, 2012. The maturities of the Company s long-term marketable

securities generally range from one to five years.

As of March 30, 2013 and September 29, 2012, gross unrealized

losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

As of March 30, 2013, the Company considered the declines in market value of its marketable securities investment portfolio to be temporary in nature and did not consider any of its investments

other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade,

with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company

reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it

will be required to sell, the investment before recovery of the investment s cost basis. During the three- and six-month periods ended March 30, 2013 and March 31, 2012, the Company did not recognize any significant impairment

charges.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. The Company may enter into

foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost of sales, on net investments in certain foreign subsidiaries, and on certain existing

assets and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the

Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may

hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases

generally up to six months.

To help protect the net investment in a foreign operation from adverse changes in foreign

currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and

losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not

limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency

exchange rates.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The

Company s accounting treatment of these instruments is based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income

( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net

investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

The Company had a net deferred gain of $517 million and a net deferred loss of $240 million associated with cash flow hedges, net of

taxes, recorded in AOCI as of March 30, 2013 and September 29, 2012, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the

related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. The majority of the Company s

hedged transactions as of March 30, 2013 are expected to occur within six months.

Derivative instruments designated as

cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated

with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of

other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 30, 2013 and March 31,

2012.

The Company s unrealized net gains and losses on net investment hedges, included in the cumulative translation

adjustment account of AOCI, were not significant as of March 30, 2013 and September 29, 2012. The ineffective portions of and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.

The gain/loss recognized in other income and expense for foreign currency forward and option

contracts not designated as hedging instruments was not significant during the three- and six-month periods ended March 30, 2013 and March 31, 2012, respectively. These amounts represent the net gain or loss on the derivative contracts and

do not include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.

The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as

of March 30, 2013 and September 29, 2012 (in millions):

March 30, 2013

September 29, 2012

Notional

Principal

Credit Risk

Amounts

Notional

Principal

Credit Risk

Amounts

Instruments designated as accounting hedges:

Foreign exchange contracts

30,925

1,026

41,970

140

Instruments not designated as accounting hedges:

Foreign exchange contracts

17,001

134

13,403

12

The notional principal amounts for outstanding derivative instruments provide one measure of the

transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that

are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be

further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal

and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately

realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of

transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments

fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of March 30, 2013, the Company received $940 million of cash collateral related to the

derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 29, 2012, the Company posted cash collateral related to the derivative

instruments under its collateral security arrangements of $278 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit-risk related

contingent features that would require it to post additional collateral as of March 30, 2013 or September 29, 2012.

10

The following tables show the Company s derivative instruments at gross fair value as

reflected in the Condensed Consolidated Balance Sheets as of March 30, 2013 and September 29, 2012 (in millions):

March 30, 2013

Fair Value of

Derivatives

Designated

as Hedge

Instruments

Fair Value of

Derivatives

Not Designated